A Phase II Study of Carboplatin plus Gemcitabine in Metastatic Non-Small Cell Lung Cancer

Abstracts/Posters/Presentations:

• Ng E, Sandler A, Einhorn L. A Phase II Study of Carboplatin Plus Gemcitabine in Non-Small Cell Lung Cancer (NSCLC). A Hoosier Oncology Group Trial LUN96-2. Accepted to the ASCO annual meeting May 16-19, 1998, Los Angeles, CA.

Manuscripts/Articles:

• Ng EW, Sandler AB, Robinson L, Einhorn LH. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study. Am J Clin Oncol. 1999 Dec;22(6):550-3. See abstract.